dimanche 15 novembre 2026
RechercherExplore
fr.via.news
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· April 4, 2026

JPMorgan Says Lamb Weston Holdings (LW) Q3 Results Were Better Than Feared

View original at finance.yahoo.com
JPMorgan Says Lamb Weston Holdings (LW) Q3 Results Were Better Than Feared Lamb Weston Holdings, Inc. (NYSE:LW) is one of the 10 Best Stocks That Beat Earnings Estimates…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The quarter was supported by continued strength in North America and disciplined execution, while highlighting ongoing efforts to align supply and demand and manage a competitive international environment

    60% confidence

  • Certain AI stocks offer greater upside potential and carry less downside risk than Lamb Weston

    60% confidence

  • JPMorgan maintained a Neutral rating on Lamb Weston shares

    60% confidence

  • Lamb Weston delivered a Q3 EPS beat, driven by stronger-than-expected performance in North America that offset international weakness, higher interest expense, and tax impacts

    60% confidence

  • The outlook reflects currency benefits, tariff impacts, ongoing disruption in parts of the Middle East, and the inclusion of a 53rd week in fiscal 2026

    60% confidence

  • The results were better than feared, noting the company narrowed its full-year EBITDA guidance while raising the midpoint, signaling stabilization in North America alongside more predictable international pressures

    60% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,997
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,997 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
JPMorgan Says Lamb Weston Holdings (LW) Q3 Results Were Better Than Feared: Source | Via News | fr.via.news